Related references
Note: Only part of the references are listed.Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?
Aleksandra Ostapiuk et al.
CNS NEUROSCIENCE & THERAPEUTICS (2022)
The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice
Sylvain Lamoine et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The microRNA-455 Null Mouse Has Memory Deficit and Increased Anxiety, Targeting Key Genes Involved in Alzheimer's Disease
Tracey E. Swingler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Does the human ventromedial prefrontal cortex support fear learning, fear extinction or both? A commentary on subregional contributions
Simone Battaglia et al.
MOLECULAR PSYCHIATRY (2022)
Neurobiological advances of learned fear in humans
Simone Battaglia
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2022)
On the Antioxidant Properties of L-Kynurenine: An Efficient ROS Scavenger and Enhancer of Rat Brain Antioxidant Defense
Daniela Ramirez Ortega et al.
ANTIOXIDANTS (2022)
Inflammation and Rho-Associated Protein Kinase-Induced Brain Changes in Vascular Dementia
Eun Chae Lee et al.
BIOMEDICINES (2022)
Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research
Eleonora Spekker et al.
BIOMEDICINES (2022)
Cerebellar and Striatal Implications in Autism Spectrum Disorders: From Clinical Observations to Animal Models
Mathieu Thabault et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Hyperthermia and Serotonin: The Quest for a Better Cyproheptadine
Georg A. Petroianu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The Neurobiological Correlates of Gaze Perception in Healthy Individuals and Neurologic Patients
Simone Battaglia et al.
BIOMEDICINES (2022)
Addiction and the kynurenine pathway: A new dancing couple?
Nuria Morales-Puerto et al.
PHARMACOLOGY & THERAPEUTICS (2021)
The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives
Katarzyna Ciapala et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Kynurenic Acid Electrochemical Immunosensor: Blood-Based Diagnosis of Alzheimer's Disease
Jose Marrugo-Ramirez et al.
BIOSENSORS-BASEL (2021)
Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia
Banny Silva Barbosa Correia et al.
BIOMEDICINES (2021)
Are 5-HT1 receptor agonists effective anti-migraine drugs?
Masaru Tanaka et al.
EXPERT OPINION ON PHARMACOTHERAPY (2021)
Don't Hurt Me No More: State-dependent Transcranial Magnetic Stimulation for the treatment of specific phobia
Sara Borgomaneri et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
Effect of dural inflammatory soup application on activation and sensitization markers in the caudal trigeminal nucleus of the rat and the modulatory effects of sumatriptan and kynurenic acid
Eleonora Spekker et al.
JOURNAL OF HEADACHE AND PAIN (2021)
Modulation of Long-Term Potentiation by Gamma Frequency Transcranial Alternating Current Stimulation in Transgenic Mouse Models of Alzheimer's Disease
Won-Hyeong Jeong et al.
BRAIN SCIENCES (2021)
Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Manuela Simonato et al.
BIOMEDICINES (2021)
Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis
Bibiana Quirant-Sanchez et al.
BIOMEDICINES (2021)
Modeling Functional Limitations, Gait Impairments, and Muscle Pathology in Alzheimer's Disease: Studies in the 3xTg-AD Mice
Lidia Castillo-Mariqueo et al.
BIOMEDICINES (2021)
Crosstalk between Existential Phenomenological Psychotherapy and Neurological Sciences in Mood and Anxiety Disorders
Lehel Balogh et al.
BIOMEDICINES (2021)
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons
Paola Sini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders
Michal Fila et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Memories are not written in stone: Re-writing fear memories by means of non-invasive brain stimulation and optogenetic manipulations
Sara Borgomaneri et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Monitoring the kynurenine system: Concentrations, ratios or what else?
Masaru Tanaka et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2021)
Fine-Tuning the PI3K/Akt Signaling Pathway Intensity by Sex and Genotype-Load: Sex-Dependent Homozygotic Threshold for Somatic Growth but Feminization of Anxious Phenotype in Middle-Aged PDK1 K465E Knock-In and Heterozygous Mice
Mikel Santana-Santana et al.
BIOMEDICINES (2021)
Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway
Masaru Tanaka et al.
BIOMEDICINES (2021)
Survival Bias and Crosstalk between Chronological and Behavioral Age: Age- and Genotype-Sensitivity Tests Define Behavioral Signatures in Middle-Aged, Old, and Long-Lived Mice with Normal and AD-Associated Aging
Lydia Gimenez-Llort et al.
BIOMEDICINES (2021)
The Oscillatory Profile Induced by the Anxiogenic Drug FG-7142 in the Amygdala-Hippocampal Network Is Reversed by Infralimbic Deep Brain Stimulation: Relevance for Mood Disorders
Hanna Vila-Merkle et al.
BIOMEDICINES (2021)
Genotype Load Modulates Amyloid Burden and Anxiety-Like Patterns in Male 3xTg-AD Survivors despite Similar Neuro-Immunoendocrine, Synaptic and Cognitive Impairments
Aida Muntsant et al.
BIOMEDICINES (2021)
Chronic Lithium Treatment Affects Anxious Behaviors and theExpression of Serotonergic Genes in Midbrain Raphe Nuclei of Defeated Male Mice
Dmitry A. Smagin et al.
BIOMEDICINES (2021)
Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
Masaru Tanaka et al.
MOLECULES (2020)
Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
Luyu Fan et al.
NATURE COMMUNICATIONS (2020)
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
Masaru Tanaka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Antidepressant-like effects of kynurenic acid in a modified forced swim test
Masaru Tanaka et al.
PHARMACOLOGICAL REPORTS (2020)
State-Dependent TMS over Prefrontal Cortex Disrupts Fear-Memory Reconsolidation and Prevents the Return of Fear
Sara Borgomaneri et al.
CURRENT BIOLOGY (2020)
The Role of the Kynurenine Signaling Pathway in Different Chronic Pain Conditions and Potential Use of Therapeutic Agents
Filip Jovanovic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Revaluing the Role of vmPFC in the Acquisition of Pavlovian Threat Conditioning in Humans
Simone Battaglia et al.
JOURNAL OF NEUROSCIENCE (2020)
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
Hisayuki Erabi et al.
SCIENTIFIC REPORTS (2020)
Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
Nora Torok et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis
Charlotte Hunt et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Serum Kynurenines Correlate With Depressive Symptoms and Disability in Poststroke Patients: A Cross-sectional Study
Paul Carrillo-Mora et al.
NEUROREHABILITATION AND NEURAL REPAIR (2020)
Context-dependent extinction of threat memories: influences of healthy aging
Simone Battaglia et al.
SCIENTIFIC REPORTS (2018)
Mediofrontal Negativity Signals Unexpected Timing of Salient Outcomes
Sara Garofalo et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2017)
Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction
Levente Szalardy et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Alzheimer’s Disease, Astrocytes and Kynurenines
Livia Dezsi et al.
Current Alzheimer Research (2016)
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects
Zsofia Majlath et al.
CURRENT NEUROPHARMACOLOGY (2016)
Targeting of the kynurenic acid across the blood-brain barrier by core-shell nanoparticles
N. Varga et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015)
Denes Zadori et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
The action of neuropeptide AF on passive avoidance learning. Involvement of neurotransmitters
Miklos Palotai et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2016)
Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons
Klas R. Linderholm et al.
NEUROPHARMACOLOGY (2016)
Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: Implications for schizophrenia
Michelle L. Pershing et al.
NEUROPHARMACOLOGY (2015)
Neuropeptide AF induces anxiety-like and antidepressant-like behavior in mice
Miklos Palotai et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Neurotransmissions of antidepressant-like effects of neuromedin U-23 in mice
Masaru Tanaka et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Inhibition of Opioid Receptor Mediated G-Protein Activity After Chronic Administration of Kynurenic Acid and its Derivative without Direct Binding to Opioid Receptors
Ferenc Zador et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Determination of binding capacity and adsorption enthalpy between Human Glutamate Receptor (GluR1) peptide fragments and kynurenic acid by surface plasmon resonance experiments
E. Csapo et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors
Janos Tajti et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Reduction of Brain Kynurenic Acid Improves Cognitive Function
Rouba Kozak et al.
JOURNAL OF NEUROSCIENCE (2014)
A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats
Ajeesh Koshy Cherian et al.
NEUROPHARMACOLOGY (2014)
Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats
Ana Pocivavsek et al.
PSYCHOPHARMACOLOGY (2014)
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
Zuzana Justinova et al.
NATURE NEUROSCIENCE (2013)
Kynurenines in the CNS: recent advances and new questions
Laszlo Vecsei et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
POST-ISCHEMIC TREATMENT WITH L-KYNURENINE SULFATE EXACERBATES NEURONAL DAMAGE AFTER TRANSIENT MIDDLE CEREBRAL ARTERY OCCLUSION
L. Gellert et al.
NEUROSCIENCE (2013)
Paradox effects of kynurenines on LTP induction in the Wistar rat. An in vivo study
I. Demeter et al.
NEUROSCIENCE LETTERS (2013)
Neurotransmissions of antidepressant-like effects of kisspeptin-13
M. Tanaka et al.
REGULATORY PEPTIDES (2013)
An expanding range of targets for kynurenine metabolites of tryptophan
Trevor W. Stone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning
Gyula Telegdy et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Neurotransmission of the antidepressant-like effects of the growth hormone-releasing hormone antagonist MZ-4-71
M. Tanaka et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat
Virginie Chauvel et al.
EXPERIMENTAL NEUROLOGY (2012)
A review of the effects of memantine on clinical progression in Alzheimer's disease
David Wilkinson
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Behavioural studies with a newly developed neuroprotective KYNA-amide
Levente Gellert et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
Flavio Moroni et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study Special issue related to Kynurenine
Ildiko Demeter et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Lack of Modulation of Nicotinic Acetylcholine Alpha-7 Receptor Currents by Kynurenic Acid in Adult Hippocampal Interneurons
Peter Dobelis et al.
PLOS ONE (2012)
Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice
Gyula Telegdy et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Endogenous activation of nAChRs and NMDA receptors contributes to the excitability of CA1 stratum radiatum interneurons in rat hippocampal slices: Effects of kynurenic acid
Manickavasagom Alkondon et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Synthesis and biological effects of some kynurenic acid analogs
K. Nagy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Antidepressant-like effects of urocortin 3 fragments
M. Tanaka et al.
BRAIN RESEARCH BULLETIN (2011)
Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia
Levente Gellert et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Memantine in dementia: a review of the current evidence
Nathan Herrmann et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease
Denes Zadori et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast
Cristina Cosi et al.
NEUROPHARMACOLOGY (2011)
Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: Implications of modulating kynurenate as a protective strategy
Daniela Silva-Adaya et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus
Paul Carrillo-Mora et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Reduction of Endogenous Kynurenic Acid Formation Enhances Extracellular Glutamate, Hippocampal Plasticity, and Cognitive Behavior
Michelle C. Potter et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Effects of the LHRH antagonist Cetrorelix on affective and cognitive functions in rats
G. Telegdy et al.
REGULATORY PEPTIDES (2010)
L-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus
Eniko Vamos et al.
NEUROPHARMACOLOGY (2009)
Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels
M. H. Selina Mok et al.
NEUROPHARMACOLOGY (2009)
β-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling
Elzbieta Luchowska et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Allosteric modulation of α7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission
J. J. Arnaiz-Cot et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
The Janus-face kynurenic acid
Eva Rozsa et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus
Katalin Sas et al.
NEUROBIOLOGY OF DISEASE (2008)
Differential trafficking of AMPA and NMDA receptors during long-term potentiation in awake adult animals
Joanna M. Williams et al.
JOURNAL OF NEUROSCIENCE (2007)
Antinociceptive interactions of triple and quadruple combinations of endogenous ligands at the spinal level
Gyongyi Horvath et al.
BRAIN RESEARCH (2007)
Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats
Trevor W. Stone
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35
Jinghong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Kynurenic acid has a dual action on AMPA receptor responses
Christina Prescott et al.
NEUROSCIENCE LETTERS (2006)
Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease
Z Hartai et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Involvement of neurotransmitters in urocortin-induced passive avoidance learning in mice
G Telegdy et al.
BRAIN RESEARCH BULLETIN (2005)
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram)
N Galeotti et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2003)
The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression:: Physiopathological implications
C Hilmas et al.
JOURNAL OF NEUROSCIENCE (2001)